FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Friedman Michael Jordan
2. Issuer Name and Ticker or Trading Symbol

INNOVATIVE MEDTECH, INC. [ IMTH ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    __X__ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
President
(Last)          (First)          (Middle)

280 MADISON AVENUE, SUITE 1005
3. Date of Earliest Transaction (MM/DD/YYYY)

3/9/2021
(Street)

NEW YORK, NY 10016
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 3/9/2021  J  17694 A$0.0001 17694 D  
Series A Preferred Stock 3/9/2021  J  4240 A$0.0001 4240 D  
Common Stock 3/25/2021  J  3400913 A$0.01 3418607 I By Red Halo, LLC 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option $1.56 5/2/2022 5/2/2022 P   50000    5/2/2022 5/2/2029 Common Stock 50000 $1.56 50000 I By Red Halo, LLC 
Option $1.56 5/2/2022 5/2/2022 P   100000    5/2/2022 (1)5/2/2029 Common Stock 100000 $1.56 150000 I By Red Halo, LLC 
Option $2.00 5/2/2022 5/2/2022 P   150000    5/2/2022 (1)5/2/2029 Common Stock 150000 $2.00 300000 I By Red Halo, LLC 
Option $3.00 5/2/2022 5/2/2022 P   200000    5/2/2022 (1)5/2/2029 Common Stock 200000 $3.00 500000 I By Red Halo, LLC 
Option $4.00 5/2/2022 5/2/2022 P   250000    5/2/2022 (1)5/2/2029 Common Stock 250000 $4.00 750000 I By Red Halo, LLC 
Option $5.00 5/2/2022 5/2/2022 P   300000    5/2/2022 (1)5/2/2029 Common Stock 300000 $5.00 1050000 I By Red Halo, LLC 
Option $6.00 5/2/2022 5/2/2022 P   350000    5/2/2022 (1)5/2/2029 Common Stock 350000 $6.00 1400000 I By Red Halo, LLC 

Explanation of Responses:
(1) As described in the issuer's Current Report on Form 8-K filed on May 27, 2022, these options are not exercisable until certain revenue milestones are met by the issuer.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Friedman Michael Jordan
280 MADISON AVENUE, SUITE 1005
NEW YORK, NY 10016
XXPresident

Signatures
/s/ Michael Jordan Friedman6/17/2022
**Signature of Reporting PersonDate


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Innovative MedTech (PK) (USOTC:IMTH)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Innovative MedTech (PK) Charts.
Innovative MedTech (PK) (USOTC:IMTH)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Innovative MedTech (PK) Charts.